| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
|
J Clin Oncol
|
1988
|
2.37
|
|
2
|
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
|
Arch Ophthalmol
|
1996
|
2.35
|
|
3
|
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma.
|
N Engl J Med
|
1991
|
2.32
|
|
4
|
Second primary malignancies following diagnosis of small-cell lung cancer.
|
J Clin Oncol
|
1992
|
1.77
|
|
5
|
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
|
Cancer Res
|
1998
|
1.70
|
|
6
|
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.
|
Clin Cancer Res
|
1996
|
1.57
|
|
7
|
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
|
J Clin Oncol
|
1984
|
1.51
|
|
8
|
Ocular involvement in neuroblastoma: prognostic implications.
|
Ophthalmology
|
1984
|
1.16
|
|
9
|
Neurologic disorders in patients with small cell lung cancer.
|
Cancer
|
1987
|
1.15
|
|
10
|
MYCN protein expression as a predictor of neuroblastoma prognosis.
|
Clin Cancer Res
|
1997
|
1.14
|
|
11
|
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
|
J Clin Oncol
|
1985
|
1.08
|
|
12
|
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
|
J Clin Oncol
|
1991
|
1.06
|
|
13
|
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.
|
Cancer Res
|
1999
|
1.02
|
|
14
|
Superior vena caval obstruction syndrome in small cell lung cancer.
|
Cancer
|
1986
|
1.00
|
|
15
|
Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?
|
CMAJ
|
1994
|
1.00
|
|
16
|
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.
|
J Clin Oncol
|
1993
|
1.00
|
|
17
|
Is bone marrow examination in small-cell lung cancer really necessary?
|
Ann Intern Med
|
1986
|
0.97
|
|
18
|
P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy.
|
J Natl Cancer Inst
|
1997
|
0.94
|
|
19
|
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.
|
J Clin Oncol
|
1985
|
0.94
|
|
20
|
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer.
|
Can J Urol
|
2004
|
0.92
|
|
21
|
Second primary respiratory tract malignancies in glottic carcinoma.
|
Cancer
|
1980
|
0.92
|
|
22
|
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer.
|
Breast Cancer Res Treat
|
1997
|
0.88
|
|
23
|
A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.
|
Clin Oncol (R Coll Radiol)
|
2008
|
0.86
|
|
24
|
Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
|
Arch Intern Med
|
1984
|
0.86
|
|
25
|
Results of treating Hodgkin's disease without a policy of laparotomy staging.
|
Cancer Treat Rep
|
1982
|
0.86
|
|
26
|
Carcinoma of the esophagus: pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure.
|
Cancer
|
1979
|
0.85
|
|
27
|
Modulatory activity of chemotherapeutic agents on phagocytosis and intracellular bactericidal activity of human polymorphonuclear and mononuclear phagocytes.
|
Cancer Res
|
1983
|
0.82
|
|
28
|
Self and external management compared with psychotherapy in the control of obesity.
|
Behav Res Ther
|
1977
|
0.82
|
|
29
|
Massive pulmonary collapse during anesthesia: a case report.
|
Anesth Analg
|
1972
|
0.81
|
|
30
|
Multidrug resistance in cancers of childhood: clinical relevance and circumvention.
|
Adv Pharmacol
|
1993
|
0.81
|
|
31
|
Nd-YAG laser-induced endobronchial burn. Management and long-term follow-up.
|
Chest
|
1989
|
0.81
|
|
32
|
The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma.
|
Br J Surg
|
1985
|
0.81
|
|
33
|
PSA doubling time of prostate carcinoma managed with watchful observation alone.
|
Int J Radiat Oncol Biol Phys
|
2001
|
0.80
|
|
34
|
Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study.
|
Breast Cancer Res Treat
|
1995
|
0.80
|
|
35
|
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1.
|
Breast Cancer Res Treat
|
1997
|
0.80
|
|
36
|
Hydrogen-bonded complexes of adenine and thymine nucleoside alkyl phosphotriesters in deuteriochloroform.
|
Biochemistry
|
1973
|
0.80
|
|
37
|
Multidrug resistance in pediatric malignancies.
|
Hematol Oncol Clin North Am
|
1995
|
0.80
|
|
38
|
Fatal mistaken identity.
|
Am Rev Respir Dis
|
1991
|
0.79
|
|
39
|
First-line therapy with VP-16 and cisplatin for small-cell lung cancer.
|
Semin Oncol
|
1986
|
0.78
|
|
40
|
Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
|
Hematol Oncol Clin North Am
|
1994
|
0.77
|
|
41
|
Is there a progression of histologic grade from radical prostatectomy to local recurrence in patients with clinically isolated local recurrence following surgery?
|
Can J Urol
|
2003
|
0.77
|
|
42
|
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
|
Cancer Treat Rep
|
1982
|
0.76
|
|
43
|
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
|
Am J Hosp Pharm
|
1986
|
0.75
|
|
44
|
Radiotherapy alone in breast cancer. Analysis of tumor and lymph node radiation doses and treatment-related complications. The experience of the Gustave-Roussy Institute and the Princess Margaret Hospital.
|
Radiother Oncol
|
1993
|
0.75
|
|
45
|
Diagnosis and reversal of multidrug resistance in paediatric cancers.
|
Eur J Cancer
|
1996
|
0.75
|
|
46
|
Multidrug drug resistance in pediatric sarcomas.
|
Hematol Oncol Clin North Am
|
1995
|
0.75
|
|
47
|
Modulation of phagocytosis and bactericidal activity of human polymorphonuclear and mononuclear phagocytes by antiarthritic agents.
|
J Rheumatol
|
1983
|
0.75
|
|
48
|
Hydrogen exchange in photohydrates of cytosine derivatives.
|
Biochim Biophys Acta
|
1970
|
0.75
|
|
49
|
Predictive value of staging investigations in patients with clinical stage I malignant melanoma.
|
Plast Reconstr Surg
|
1987
|
0.75
|
|
50
|
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
|
Am J Clin Oncol
|
1986
|
0.75
|
|
51
|
Prognostic factors in T2 glottic cancer.
|
Cancer
|
1980
|
0.75
|
|
52
|
Herpes zoster in patients with small-cell carcinoma of the lung receiving combined modality treatment.
|
Ann Intern Med
|
1980
|
0.75
|
|
53
|
Preoperative screening for sickle cell trait.
|
JAMA
|
1988
|
0.75
|
|
54
|
Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review.
|
Int J Obstet Anesth
|
2008
|
0.75
|
|
55
|
Observer variation in abdominal CT.
|
Invest Radiol
|
1985
|
0.75
|
|
56
|
Intraoperative hyperkalemia as a triggering mechanism or presenting sign of malignant hyperthermia in two patients with chronic renal failure.
|
Anesthesiology
|
1995
|
0.75
|
|
57
|
Herpes zoster in patients with carcinoma of the lung.
|
Am J Med
|
1982
|
0.75
|
|
58
|
Complexes of oligonucleotides with polynucleotides on solid supports.
|
Biochemistry
|
1974
|
0.75
|